Advisory Board January 9, 2025

In an interview with STAT’s Matthew Herper, FDA Commissioner Robert Califf reflected on his time leading the agency and explained why he’s “concerned” about what could happen during the incoming Trump administration.

Radio Advisory: What will happen in healthcare following the election?

Califf looks back on his time as FDA commissioner

In the interview, Califf said that his confirmation as FDA commissioner in February 2022, which was the second time he had been confirmed to the post, was “a pretty low time.”

“As the waves came through on Covid, the constant realization that people were dying who didn’t need to, if they just took the vaccine, was really wearing,” he said.

On Califf’s first day as commissioner, Abbott announced a...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Congress / White House, FDA, Interview / Q&A, Trends
Supporting the Development of Drugs for Rare Diseases — The Importance of Regulatory Transparency
Opinion: To fight for those with rare diseases, Trump must reform and modernize the FDA thoughtfully
5 Rare Diseases That Now Have Their First FDA-Approved Treatments
This Bill Could Make It Legal for AI to Prescribe Medicine
STAT+: Trump’s FDA navigates layoffs, exits, and a new hire

Share This Article